Brigit Biofarmaka Teknologi Tbk. vs Northcliff Citranusa Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Northcliff Citranusa Indonesia Tbk. trades at Rp51 (market cap 29.84B). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 5.6× Northcliff Citranusa Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| OBAT | SKYB | |
|---|---|---|
Market Cap | 166.01B | 29.84B |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Skybee (the company) was established under its original name of PT Kreatip Komunikacitra base on notarial deed No.12 of Lilianan Indrawati, S.H, dated on Jun 10, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 03 of Leolin J, S.H., dated Mar 12, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on SKYB →